199 related articles for article (PubMed ID: 23396531)
1. Modelling the evolution of genetic instability during tumour progression.
S Datta R; Gutteridge A; Swanton C; Maley CC; Graham TA
Evol Appl; 2013 Jan; 6(1):20-33. PubMed ID: 23396531
[TBL] [Abstract][Full Text] [Related]
2. Evolution of genetic instability in heterogeneous tumors.
Asatryan AD; Komarova NL
J Theor Biol; 2016 May; 396():1-12. PubMed ID: 26826489
[TBL] [Abstract][Full Text] [Related]
3. Negative clonal selection in tumor evolution.
Beckman RA; Loeb LA
Genetics; 2005 Dec; 171(4):2123-31. PubMed ID: 16143627
[TBL] [Abstract][Full Text] [Related]
4. Genomic clustering of fitness-affecting mutations favors the evolution of chromosomal instability.
Raynes Y; Weinreich DM
Evol Appl; 2019 Feb; 12(2):301-313. PubMed ID: 30697341
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
Beckman RA
Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
[TBL] [Abstract][Full Text] [Related]
6. Clonal evolution driven by superdriver mutations.
Grossmann P; Cristea S; Beerenwinkel N
BMC Evol Biol; 2020 Jul; 20(1):89. PubMed ID: 32689942
[TBL] [Abstract][Full Text] [Related]
7. Mutator mutations enhance tumorigenic efficiency across fitness landscapes.
Beckman RA
PLoS One; 2009 Jun; 4(6):e5860. PubMed ID: 19517009
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of carcinogenesis with and without a mutator mutation.
Beckman RA; Loeb LA
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14140-5. PubMed ID: 16966602
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability and carcinogenesis: an update.
Abdel-Rahman WM
Curr Genomics; 2008 Dec; 9(8):535-41. PubMed ID: 19516960
[TBL] [Abstract][Full Text] [Related]
10. Cancer heterogeneity: converting a limitation into a source of biologic information.
Rübben A; Araujo A
J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
[TBL] [Abstract][Full Text] [Related]
11. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
12. The role of advantageous mutations in enhancing the evolution of a recombination modifier.
Hartfield M; Otto SP; Keightley PD
Genetics; 2010 Apr; 184(4):1153-64. PubMed ID: 20139345
[TBL] [Abstract][Full Text] [Related]
13. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.
Wodarz D; Newell AC; Komarova NL
J R Soc Interface; 2018 Jun; 15(143):. PubMed ID: 29875280
[TBL] [Abstract][Full Text] [Related]
14. Update of genetics in colorectal carcinomas: genomic instability and somatic evolution.
Cheah PY; Eu KW; Seow FC
Ann Acad Med Singap; 2000 May; 29(3):331-6. PubMed ID: 10976386
[TBL] [Abstract][Full Text] [Related]
15. Cancer initiation with epistatic interactions between driver and passenger mutations.
Bauer B; Siebert R; Traulsen A
J Theor Biol; 2014 Oct; 358():52-60. PubMed ID: 24859427
[TBL] [Abstract][Full Text] [Related]
16. Low mutation rates promote the evolution of advantageous traits by preventing interference from deleterious mutations.
Aoyagi Blue Y; Sakai S
Genetica; 2020 Apr; 148(2):101-108. PubMed ID: 32219589
[TBL] [Abstract][Full Text] [Related]
17. Selective pressures for and against genetic instability in cancer: a time-dependent problem.
Komarova NL; Sadovsky AV; Wan FY
J R Soc Interface; 2008 Jan; 5(18):105-21. PubMed ID: 17580291
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Mutation Rates in Rapidly Adapting Asexual Populations.
Good BH; Desai MM
Genetics; 2016 Nov; 204(3):1249-1266. PubMed ID: 27646140
[TBL] [Abstract][Full Text] [Related]
19. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
Elife; 2020 May; 9():. PubMed ID: 32423531
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy.
Komarova NL; Wodarz D
Cancer Res; 2003 Oct; 63(20):6635-42. PubMed ID: 14583456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]